Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

被引：0
|
作者：
Huizing, D. [1 ]
Aalbersberg, E. A. [1 ]
Versleijen, M. W. J. [1 ]
Tesselaar, M. E. T. [1 ]
Walraven, I. [1 ]
Lahaye, M. J. [1 ]
de Wit-van der Veen, B. J. [1 ]
Stokkel, M. P. M. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-276
引用
收藏
页码：S140 / S141
页数：2
相关论文
共 50 条
  • [1] Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy
    Huizing, Daphne M., V
    Aalbersberg, Else A.
    Versleijen, Michelle W. J.
    Tesselaar, Margot E. T.
    Walraven, Iris
    Lahaye, Max J.
    de Wit-van der Veen, Berlinda J.
    Stokkel, Marcel P. M.
    CANCER IMAGING, 2020, 20 (01)
  • [2] Early Response Assessment for Prediction of Overall Survival after Peptide Receptor Radionuclide Therapy
    Huizing, D.
    Aalbersberg, E. A.
    Versleijen, M. W. J.
    Tesselaar, M.
    Walraven, I
    Lahaye, M. J.
    De Wit-van der Veen, B. J.
    Stokkel, M. P. M.
    NEUROENDOCRINOLOGY, 2020, 110 : 257 - 257
  • [3] Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy
    Daphne M. V. Huizing
    Else A. Aalbersberg
    Michelle W. J. Versleijen
    Margot E. T. Tesselaar
    Iris Walraven
    Max J. Lahaye
    Berlinda J. de Wit–van der Veen
    Marcel P. M. Stokkel
    Cancer Imaging, 20
  • [4] Survival rates after peptide receptor radionuclide therapy
    Graewert, Stephanie
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2021, 193 (04): : 376 - 376
  • [5] The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors
    Yalchin, Mehmet
    Oliveira, Amelia
    Theocharidou, Eleni
    Pencharz, Deborah
    Navalkissoor, Shaunak
    Quigley, Ann-Marie
    Walker, Martin
    Caplin, Martyn
    Toumpanakis, Christos
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : E135 - E141
  • [6] Pretherapy Prediction of Nephrotoxicity After Peptide Radionuclide Receptor Therapy (PRRT)
    DeNardo, Gerald L.
    Macey, Daniel J.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (05) : 507 - 509
  • [7] Primary Tumor Resection Results in Superior Overall Survival after Peptide Receptor Radionuclide Therapy in Advanced Neuroendocrine Neoplasms
    Kaemmerer, D.
    Twrznik, M.
    Hommann, M.
    Hoersch, D.
    Baum, R.
    NEUROENDOCRINOLOGY, 2017, 105 : 268 - 268
  • [8] Peptide Receptor Radionuclide Therapy improves progression free and overall survival in patients who progress after resection of gastroenteropancreatic NETs
    Borbon, L.
    Sherman, S.
    Breheny, P.
    Ear, P. H.
    Menda, Y.
    Chandrasekharan, C.
    Bellizzi, A.
    O'Dorisio, T.
    Dillon, J.
    Howe, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 267 - 267
  • [9] Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients
    Aalbersberg, Else A.
    Huizing, Daphne M. V.
    Walraven, Iris
    de Wit-van der Veen, Berlinda J.
    Kulkarni, Harshad R.
    Singh, Aviral
    Stokkel, Marcel P. M.
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (09) : 1259 - 1265
  • [10] Prediction of overall survival after neoadjuvant therapy
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2025, 150 (01): : 11 - 11
12345